Based on the key indicators obtained from USANA Health's historical financial statements, USANA Health Sciences may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, USANA Health's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Total Assets is expected to grow to about 664.4 M, whereas Other Current Liabilities is forecasted to decline to about 57.3 M. Key indicators impacting USANA Health's financial strength include:
The essential information of the day-to-day investment outlook for USANA Health includes many different criteria found on its balance sheet. An individual investor should monitor USANA Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in USANA Health.
Net Income
53.56 Million
USANA
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Stock Based Compensation
Change To Account Receivables
Change To Liabilities
Other Cashflows From Investing Activities
Total Cashflows From Investing Activities
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Investments
Change To Operating Activities
Net Borrowings
Common Stock Shares Outstanding
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Liabilities And Stockholders Equity
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Long Term Debt Total
Current Deferred Revenue
Net Receivables
Common Stock Total Equity
Non Current Liabilities Total
Short Term Debt
Common Stock
Other Assets
Property Plant Equipment
Other Liab
Good Will
Intangible Assets
Short Term Investments
Net Tangible Assets
Retained Earnings Total Equity
Capital Surpluse
Deferred Long Term Liab
Non Current Liabilities Other
Deferred Long Term Asset Charges
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Interest Expense
Total Revenue
Gross Profit
Operating Income
Ebit
Ebitda
Income Tax Expense
Depreciation And Amortization
Other Operating Expenses
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Selling General Administrative
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Operating Income Net Other
Selling And Marketing Expenses
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past USANA Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of USANA Health's financial statements are interrelated, with each one affecting the others. For example, an increase in USANA Health's assets may result in an increase in income on the income statement.
Please note, the presentation of USANA Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, USANA Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of USANA Health's management manipulating its earnings.
USANA Health Stock Summary
USANA Health competes with J J, Lancaster Colony, Seneca Foods, Seneca Foods, and Bridgford Foods. USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people.
Comparative valuation techniques use various fundamental indicators to help in determining USANA Health's current stock value. Our valuation model uses many indicators to compare USANA Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across USANA Health competition to find correlations between indicators driving USANA Health's intrinsic value. More Info.
USANA Health Sciences is rated fourth in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about 0.75 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for USANA Health Sciences is roughly 1.34 . At present, USANA Health's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the USANA Health's earnings, one of the primary drivers of an investment's value.
USANA Health's Earnings Breakdown by Geography
USANA Health Sciences Systematic Risk
USANA Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. USANA Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on USANA Health Sciences correlated with the market. If Beta is less than 0 USANA Health generally moves in the opposite direction as compared to the market. If USANA Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one USANA Health Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of USANA Health is generally in the same direction as the market. If Beta > 1 USANA Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in USANA Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various USANA Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of USANA Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.43)
At present, USANA Health's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
USANA Health November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of USANA Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of USANA Health Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of USANA Health Sciences based on widely used predictive technical indicators. In general, we focus on analyzing USANA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build USANA Health's daily price indicators and compare them against related drivers.
When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance